P-stalk ribosomes identified as key regulators of immune evasion in cancer
New study reveals that specialized ribosomes, driven by cytokine signals, help tumors evade the immune system, offering a breakthrough pathway ...
Tag: Tumor
Scientists reveal how miRNAs shape cancer and offer new paths for treatment
Groundbreaking research uncovers the role of miRNAs in driving cancer while offering innovative diagnostic tools and therapies, including solutions to ...
New computational pipeline revolutionizes personalized cancer vaccine design
Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors ...
Researchers reveal mechanisms of how CDK12 alterations drive prostate cancer development
When researchers at the University of Michigan Rogel Cancer Center first identified a new subtype of aggressive prostate cancer, they knew ...
New drug could extend the lives of breast cancer patients
LMU researchers have successfully tested a new drug which can significantly extend the lives of breast cancer patients. Patients with ...
ChatGPT can be useful for preoperative MRI diagnosis of brain tumors
As artificial intelligence advances, its uses and capabilities in real-world applications continue to reach new heights that may even surpass ...
From patient to physician: EJ Beck's medical journey at NYU Langone Health
As a child, EJ Beck was treated for a rare pediatric thyroid cancer at NYU Langone Health. About 10 years ...
UCLA Health researchers showcase advances in radiation oncology at ASTRO
UCLA Health Jonsson Comprehensive Cancer Center researchers and physicians who specialize in treating patients with radiation therapies will present data ...
Cellular sludge around hunger neurons linked to worsening diabetes and obesity
Researchers uncover how the buildup of extracellular matrix proteins and sugars prevents insulin from reaching hunger-regulating neurons, leading to disrupted ...
ISM2196: A promising AI-developed WRN inhibitor for advanced metastatic cancers
Insilico Medicine("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today announced the nomination of ISM2196, an AI-driven, potential best-in-class ...
POPULAR NEWS
